Statin use and stroke outcomes in the Heart and Estrogen-Progestin Replacement Study (HERS).
Publication
, Journal Article
Bushnell, CD; Newby, LK; Goldstein, LB; Lin, F; Yaffe, K; Simon, JA
Published in: Neurology
March 23, 2004
The authors investigated the relationship between statin use and the risk of stroke in the Heart and Estrogen-Progestin Replacement Study (HERS). Despite large reductions in relative risk point estimates, statin use was not associated with differences in the risks of all fatal stroke (relative hazard [RH] 0.52, 95% CI 0.23 to 1.18, p = 0.12), fatal ischemic stroke (RH 0.51, 95% CI 0.18 to 1.45, p = 0.21), fatal hemorrhagic stroke (RH 0.18, 95% CI 0.02 to 1.46, p = 0.11), or TIA (RH 1.32, 95% CI 0.84 to 2.09, p = 0.23).
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Neurology
DOI
EISSN
1526-632X
Publication Date
March 23, 2004
Volume
62
Issue
6
Start / End Page
968 / 970
Location
United States
Related Subject Headings
- Survival Analysis
- Stroke
- Risk
- Randomized Controlled Trials as Topic
- Postmenopause
- Neurology & Neurosurgery
- Medroxyprogesterone Acetate
- Ischemic Attack, Transient
- Incidence
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
Citation
APA
Chicago
ICMJE
MLA
NLM
Bushnell, C. D., Newby, L. K., Goldstein, L. B., Lin, F., Yaffe, K., & Simon, J. A. (2004). Statin use and stroke outcomes in the Heart and Estrogen-Progestin Replacement Study (HERS). Neurology, 62(6), 968–970. https://doi.org/10.1212/01.wnl.0000115171.46508.19
Bushnell, C. D., L. K. Newby, L. B. Goldstein, F. Lin, K. Yaffe, and J. A. Simon. “Statin use and stroke outcomes in the Heart and Estrogen-Progestin Replacement Study (HERS).” Neurology 62, no. 6 (March 23, 2004): 968–70. https://doi.org/10.1212/01.wnl.0000115171.46508.19.
Bushnell CD, Newby LK, Goldstein LB, Lin F, Yaffe K, Simon JA. Statin use and stroke outcomes in the Heart and Estrogen-Progestin Replacement Study (HERS). Neurology. 2004 Mar 23;62(6):968–70.
Bushnell, C. D., et al. “Statin use and stroke outcomes in the Heart and Estrogen-Progestin Replacement Study (HERS).” Neurology, vol. 62, no. 6, Mar. 2004, pp. 968–70. Pubmed, doi:10.1212/01.wnl.0000115171.46508.19.
Bushnell CD, Newby LK, Goldstein LB, Lin F, Yaffe K, Simon JA. Statin use and stroke outcomes in the Heart and Estrogen-Progestin Replacement Study (HERS). Neurology. 2004 Mar 23;62(6):968–970.
Published In
Neurology
DOI
EISSN
1526-632X
Publication Date
March 23, 2004
Volume
62
Issue
6
Start / End Page
968 / 970
Location
United States
Related Subject Headings
- Survival Analysis
- Stroke
- Risk
- Randomized Controlled Trials as Topic
- Postmenopause
- Neurology & Neurosurgery
- Medroxyprogesterone Acetate
- Ischemic Attack, Transient
- Incidence
- Hydroxymethylglutaryl-CoA Reductase Inhibitors